Skip to main content
FDA Updates
Mylotarg Now Approved for the Treatment of Patients with CD33-Positive AML
Read More
FDA Updates
Nivolumab Receives New Indication for dMMR and MSI-H Metastatic Colorectal Cancer
Read More
FDA Updates
Besponsa a New Treatment Option for Patients with Relapsed/Refractory B-Cell ALL
Read More
FDA Updates
Kymriah First Gene Therapy Approved by the FDA, Indicated for Young Patients with B-Cell ALL and CD19
Read More
Survey End Page
Read More
Supplements
Uridine Triacetate: An Antidote to Life-Threatening 5-Fluorouracil and Capecitabine Toxicity
Wen Wee Ma, MBBS
Read More
Supplements
Serious Toxicities Associated with 5-Fluorouracil and Capecitabine: A Clinical Pharmacy Perspective
Amber Draper, PharmD, BCOP
Read More
Supplements
The Importance of Patient Education in the Management of Treatment-Related Toxicities: A Nurse’s Perspective
Melissa Hennessey Smith, MSN, AGPCNP-BC
Read More
FDA Updates
FDA News - September 2017
Read More
Original Research
Retrospective Analysis of Probiotic Effectiveness in Patients with Acute Myeloid Leukemia or Patients Undergoing Transplant Who Are Receiving Chemotherapy
Daniel J. Przybylski, PharmD, David J. Reeves, PharmD, BCOP
Read More
Page 165 of 199
Results 1641 - 1650 of 1986